Dansk uddannelsesmateriale

15. november 2016, Opdateret 27. januar 2023

Fra d. 15. november 2016 publicerer Lægemiddelstyrelsen uddannelsesmaterialer for humane lægemidler godkendt gennem den nationale procedure, den gensidige anerkendelsesprocedure og den decentrale procedure.

Fra d. 1. januar 2023 publicerer Lægemiddelstyrelsen også uddannelsesmaterialer for humane lægemidler godkendt gennem den centrale procedure og ikke med tilbagevirkende kraft.

Det er indehaveren af markedsføringstilladelsen, der har det overordnede ansvar for at uddannelsesmaterialet lever op til vilkår tilknyttet markedsføringstilladelsen, og for at Lægemiddelstyrelsen har det senest accepterede skriftlige materiale tilgængelig til publicering.

Nedenstående danske uddannelsesmaterialer er vurderet og accepteret af Lægemiddelstyrelsen.

Navn Lægemiddelform Styrke Aktiv substans Mft Indehaver Dato for publicering
RINVOQ depottabletter 15 mg Upadacitinibhemihydrat AbbVie Deutschland GmbH & Co. KG 10-11-2023
RINVOQ depottabletter 30 mg Upadacitinibhemihydrat AbbVie Deutschland GmbH & Co. KG 10-11-2023
RINVOQ depottabletter 45 mg Upadacitinibhemihydrat AbbVie Deutschland GmbH & Co. KG 08-05-2023
Rivaroxaban "Hexal" filmovertrukne tabletter 2,5 mg Rivaroxaban Hexal A/S 12-08-2024
Rivaroxaban "Hexal" filmovertrukne tabletter 10 mg Rivaroxaban Hexal A/S 12-08-2024
Rivaroxaban "Hexal" filmovertrukne tabletter 15 mg Rivaroxaban Hexal A/S 12-08-2024
Rivaroxaban "Hexal" filmovertrukne tabletter 20 mg Rivaroxaban Hexal A/S 12-08-2024
Rivaroxaban "Hexal" Startpakke filmovertrukne tabletter 15+20 mg Rivaroxaban Hexal A/S 12-08-2024
Rivaroxaban "Krka" filmovertrukne tabletter 2,5 mg Rivaroxaban KRKA d.d. Novo mesto 12-03-2024
Rivaroxaban "Krka" filmovertrukne tabletter 10 mg Rivaroxaban KRKA d.d. Novo mesto 12-03-2024
Rivaroxaban "Krka" filmovertrukne tabletter 15 mg Rivaroxaban KRKA d.d. Novo mesto 12-03-2024
Rivaroxaban "Krka" filmovertrukne tabletter 20 mg Rivaroxaban KRKA d.d. Novo mesto 12-03-2024
Rivaroxaban "Sandoz" filmovertrukne tabletter 20 mg Rivaroxaban Sandoz A/S 12-08-2024
Rivaroxaban "Sandoz" filmovertrukne tabletter 15 mg Rivaroxaban Sandoz A/S 12-08-2024
Rivaroxaban "Sandoz" filmovertrukne tabletter 2,5 mg Rivaroxaban Sandoz A/S 12-08-2024
Rivaroxaban "Sandoz" filmovertrukne tabletter 10 mg Rivaroxaban Sandoz A/S 12-08-2024
Rivaroxaban "Stada" filmovertrukne tabletter 20 mg Rivaroxaban STADA Arzneimittel AG 02-04-2024
Rivaroxaban "Stada" filmovertrukne tabletter 2,5 mg Rivaroxaban STADA Arzneimittel AG 04-03-2024
Rivaroxaban "Stada" filmovertrukne tabletter 10 mg Rivaroxaban STADA Arzneimittel AG 04-03-2024
Rivaroxaban "Stada" filmovertrukne tabletter 15 mg Rivaroxaban STADA Arzneimittel AG 04-03-2024
Rivaroxaban "Stada" kapsler, hårde 15 mg Rivaroxaban STADA Arzneimittel AG 04-03-2024
Rivaroxaban "Stada" kapsler, hårde 20 mg Rivaroxaban STADA Arzneimittel AG 04-03-2024
Rivaroxaban "Stada" Startpakke filmovertrukne tabletter 15+20 mg Rivaroxaban STADA Arzneimittel AG 04-03-2024
Rivaroxaban "Stada" Startpakke kapsler, hårde 15+20 mg Rivaroxaban STADA Arzneimittel AG 04-03-2024
Rivaroxaban "Teva" filmovertrukne tabletter 2,5 mg Rivaroxaban Teva GmbH 29-04-2024
Rivaroxaban "Teva" filmovertrukne tabletter 10 mg Rivaroxaban Teva GmbH 29-04-2024
Rivaroxaban "Teva" filmovertrukne tabletter 15 mg Rivaroxaban Teva GmbH 29-04-2024
Rivaroxaban "Teva" filmovertrukne tabletter 20 mg Rivaroxaban Teva GmbH 29-04-2024
Rivaroxaban "Tillomed" filmovertrukne tabletter 10 mg Rivaroxaban Tillomed Pharma GmbH 09-10-2024
Rivaroxaban "Tillomed" filmovertrukne tabletter 2,5 mg Rivaroxaban Tillomed Pharma GmbH 09-10-2024
Rivaroxaban "Tillomed" filmovertrukne tabletter 15 mg Rivaroxaban Tillomed Pharma GmbH 09-10-2024
Rivaroxaban "Tillomed" filmovertrukne tabletter 20 mg Rivaroxaban Tillomed Pharma GmbH 09-10-2024
Rivaroxaban "Tillomed" Startpakke filmovertrukne tabletter 15 mg+20 mg Rivaroxaban Tillomed Pharma GmbH 09-10-2024
Rivaroxaban Accord filmovertrukne tabletter 2,5 mg Rivaroxaban Accord Healthcare S.L.U. 12-08-2024
Rivaroxaban Accord filmovertrukne tabletter 10 mg Rivaroxaban Accord Healthcare S.L.U. 12-08-2024
Rivaroxaban Accord filmovertrukne tabletter 15 mg Rivaroxaban Accord Healthcare S.L.U. 12-08-2024
Rivaroxaban Accord filmovertrukne tabletter 20 mg Rivaroxaban Accord Healthcare S.L.U. 12-08-2024
Rivaroxaban Accord Startpakke filmovertrukne tabletter 15 mg + 20 mg Rivaroxaban Accord Healthcare S.L.U. 12-08-2024
Rivaroxaban Viatris filmovertrukne tabletter 2,5 mg Rivaroxaban Viatris Limited 19-03-2024
Rivaroxaban Viatris filmovertrukne tabletter 10 mg Rivaroxaban Viatris Limited 19-03-2024
Rivaroxaban Viatris filmovertrukne tabletter 15 mg Rivaroxaban Viatris Limited 19-03-2024
Rivaroxaban Viatris filmovertrukne tabletter 20 mg Rivaroxaban Viatris Limited 19-03-2024
Rivaroxaban Viatris Startpakke filmovertrukne tabletter 15 mg + 20 mg Rivaroxaban Viatris Limited 19-03-2024
Rivastor depotplastre 4,6 mg/24 timer RIVASTIGMIN Orion Corporation 14-08-2020
Rivastor depotplastre 9,5 mg/24 timer RIVASTIGMIN Orion Corporation 14-08-2020
Rivastor depotplastre 13,3 mg/24 timer RIVASTIGMIN Orion Corporation 14-08-2020
Rivaxa filmovertrukne tabletter 2,5 mg Rivaroxaban Glenmark Pharmaceuticals Nordic AB 08-05-2024
Rivaxa filmovertrukne tabletter 10 mg Rivaroxaban Glenmark Pharmaceuticals Nordic AB 08-05-2024
Rivaxa filmovertrukne tabletter 15 mg Rivaroxaban Glenmark Pharmaceuticals Nordic AB 08-05-2024
Rivaxa filmovertrukne tabletter 20 mg Rivaroxaban Glenmark Pharmaceuticals Nordic AB 08-05-2024
Rivaxa Startpakke filmovertrukne tabletter 15+20 mg Rivaroxaban Glenmark Pharmaceuticals Nordic AB 08-05-2024